KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Income from Continuing Operations (2016 - 2025)

Gilead Sciences' Income from Continuing Operations history spans 17 years, with the latest figure at 2528000000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 41.86% year-over-year to 2528000000.0; the TTM value through Dec 2025 reached 8856000000.0, up 1748.85%, while the annual FY2025 figure was 8510000000.0, 1676.62% up from the prior year.
  • Income from Continuing Operations reached 2528000000.0 in Q4 2025 per GILD's latest filing, down from 3052000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3052000000.0 in Q3 2025 to a low of 4171000000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 1285650000.0, with a median of 1566000000.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: surged 8100.0% in 2023, then plummeted 523.88% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 376000000.0 in 2021, then surged by 334.31% to 1633000000.0 in 2022, then fell by 13.29% to 1416000000.0 in 2023, then grew by 25.85% to 1782000000.0 in 2024, then surged by 41.86% to 2528000000.0 in 2025.
  • Per Business Quant, the three most recent readings for GILD's Income from Continuing Operations are 2528000000.0 (Q4 2025), 3052000000.0 (Q3 2025), and 1961000000.0 (Q2 2025).